verapamil has been researched along with succinylcholine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (61.54) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bake, I; Buttazzoni, E; Csongrady, A; Pfänder, C; Schneider, M; Tarmann, H | 1 |
| Baeyens, JM; Carlos, R; Del Pozo, E; Ocaña, M | 1 |
| Fletcher, JE; Huggins, FJ; Rosenberg, H | 1 |
| Chang, CC; Chiou, LC; Hong, SJ; Huang, CY; Hwang, LL | 1 |
| Adam, LP; Henderson, EG | 1 |
| Baeyens, JM; Carlos, R; del Pozo, E; Salvador, A | 1 |
| Foldes, FF; Gallant, EM; Gronert, GA; Rempel, WE | 1 |
| Gronert, GA; Nugent, M; Roth, JL | 1 |
| Bentley, PJ; Chiarandini, DJ | 1 |
| Durant, NN; Katz, RL; Nguyen, N | 1 |
| Howie, MB; Kramer, MG; McSweeney, TD | 1 |
1 review(s) available for verapamil and succinylcholine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for verapamil and succinylcholine
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
[A further case of malignant hyperpyrexia and its treatment with lidocaine, methylprednisolone and verapamil (iproveratril) (author's transl)].
Topics: Acidosis; Adult; Calcium; Cryotherapy; Glucose; Halothane; Humans; Insulin; Lidocaine; Male; Malignant Hyperthermia; Methylprednisolone; Muscle Relaxants, Central; Oxygen; Succinylcholine; Verapamil | 1976 |
Differential potentiation by calcium antagonists of neuromuscular blockade induced by pancuronium and succinylcholine in cats in vivo.
Topics: Animals; Calcium Channel Blockers; Cats; Diltiazem; Dose-Response Relationship, Drug; Drug Synergism; Female; Male; Neuromuscular Blocking Agents; Nicardipine; Pancuronium; Stereoisomerism; Succinylcholine; Verapamil | 1992 |
The importance of calcium ions for in vitro malignant hyperthermia testing.
Topics: Caffeine; Calcium; Contracture; Drug Interactions; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Muscles; Nifedipine; Quinacrine; Strontium; Succinylcholine; Verapamil | 1990 |
Nicardipine inhibits axon conduction but causes dual changes of acetylcholine release in the mouse motor nerve.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Action Potentials; Animals; Axonal Transport; Axons; Chick Embryo; Diaphragm; Diltiazem; Female; In Vitro Techniques; Male; Mice; Mice, Inbred ICR; Motor Neurons; Muscle Contraction; Nicardipine; Nifedipine; Sodium Channels; Succinylcholine; Verapamil | 1989 |
Augmentation of succinylcholine-induced neuromuscular blockade by calcium channel antagonists.
Topics: Animals; Bepridil; Calcium Channel Blockers; Drug Synergism; In Vitro Techniques; Neuromuscular Junction; Nicardipine; Nifedipine; Pyrrolidines; Rana pipiens; Receptors, Nicotinic; Succinylcholine; Synaptic Transmission; Verapamil | 1986 |
Differential effects of calcium channel blocking agents on pancuronium- and suxamethonium-induced neuromuscular blockade.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Drug Synergism; Female; In Vitro Techniques; Muscle Contraction; Neuromuscular Junction; Nicardipine; Pancuronium; Rats; Rats, Inbred Strains; Succinylcholine; Verapamil | 1988 |
Verapamil is not a therapeutic adjunct to dantrolene in porcine malignant hyperthermia.
Topics: Anesthesia, Inhalation; Animals; Blood Gas Analysis; Blood Pressure; Dantrolene; Drug Synergism; Halothane; Heart Rate; Infusions, Parenteral; Malignant Hyperthermia; Muscle Contraction; Succinylcholine; Swine; Verapamil | 1985 |
Verapamil does not alter succinylcholine-induced increases in serum potassium during halothane anesthesia in normal dogs.
Topics: Anesthesia; Animals; Dogs; Halothane; Potassium; Succinylcholine; Verapamil | 1985 |
The effects of verapamil on metabolism and contractility of the toad skeletal muscle.
Topics: Acetylcholine; Animals; Bufo marinus; Caffeine; Calcium; Dinitrophenols; In Vitro Techniques; Muscle Contraction; Muscles; Oxygen Consumption; Potassium; Procaine; Propranolol; Succinylcholine; Tubocurarine; Verapamil | 1973 |
Potentiation of neuromuscular blockade by verapamil.
Topics: Animals; Blood Pressure; Bungarotoxins; Dose-Response Relationship, Drug; Drug Synergism; Electrocardiography; Heart Rate; Male; Muscle Contraction; Muscles; Neuromuscular Blocking Agents; Pancuronium; Rabbits; Succinylcholine; Verapamil | 1984 |
The effects of verapamil and diltiazem pretreatment on potassium release in dogs after the administration of succinylcholine.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Dogs; Neuromuscular Blocking Agents; Potassium; Succinylcholine; Verapamil | 1998 |